The Board will consider the following agenda items:
- Consider and approve Un-Audited Standalone and Consolidated Financial Statements for Q1 of FY2026-2027 (period ending June 30, 2026)
- Recommend dividend for the Financial Year ended March 31, 2026, if approved, subject to shareholder approval at the ensuing Annual General Meeting
- Consider any other business matters
Pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015 and the Company's Code of Conduct for prevention of Insider Trading, the trading window for dealing in the company's securities has been closed for all Designated Persons and their immediate relatives. The closure period is effective from July 1, 2026 until 48 hours after the declaration of Financial Results (Un-Audited Standalone & Consolidated) for the first quarter ended June 30, 2026 (both days inclusive). All designated persons and their immediate relatives are prohibited from dealing in the company's securities during this period.
The communication was digitally signed by Ms. Pooja Thorave, Company Secretary & Compliance Officer (Membership No. A74339) on August 06, 2026 at 11:59:02 +05:30.